Interaction of pathogens with host cholesterol metabolism

Current Opinion in Lipidology

Volumn 25, Issue 5, 2014, Pages 333-338

  Sviridov, Dmitri ^a   Bukrinsky, Michael ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cholesterol; Infections; Metabolic diseases

Indexed keywords

CHOLESTEROL; MICRORNA; PRION;

CHOLESTEROL METABOLISM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; LIPID RAFT; LIPOPROTEIN METABOLISM; METABOLIC DISORDER; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; CELL MEMBRANE; CYTOPLASM; GENETICS; INFECTION; LIPID METABOLISM; METABOLISM; PATHOGENICITY; PATHOLOGY; PRION;

PROTOZOA;

CHOLESTEROL; CYTOPLASM; HOST-PATHOGEN INTERACTIONS; HUMANS; INFECTION; LIPID METABOLISM; MEMBRANE MICRODOMAINS; MICRORNAS; PRIONS;

EID: 84921435745     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000106     Document Type: Review

References (66)

1. Tabas I. Cholesterol in health and disease. J Clin Invest 2002; 110: 583-590.
2. Baron GS, Wehrly K, Dorward DW, et al. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc) into contiguous membranes. EMBO J 2002; 21: 1031-1040.
3. Prior M, Lehmann S, Sy M-S, et al. Cyclodextrins inhibit replication of scrapie prion protein in cell culture. J Virol 2007; 81: 11195-11207.
4. Mangé A, Nishida N, Milhavet O, et al. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol 2000; 74: 3135-3140.
5. Cui HL, Guo B, Scicluna B, et al. Prion infection impairs cholesterol metabolism in neuronal cells. J Biol Chem 2014; 289: 789-802.
6. Takahashi T, Suzuki T. Function of membrane rafts in viral lifecycles and host cellular response. Biochem Res Int 2011; 2011: 245090.
7. Millan J, Cerny J, Horejsi V, Alonso MA. CD4 segregates into specific detergent-resistant T-cell membrane microdomains. Tissue Antigens 1999; 53: 33-40.
8. Kamiyama H, Yoshii H, Tanaka Y, et al. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection. Virology 2009; 386: 23-31.
9. van Wilgenburg B, Moore MD, James WS, Cowley SA. The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4. PLoS One 2014; 9: E86071.
10. Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A 2001; 98: 13925-13930.
11. Bhattacharya J, Repik A, Clapham PR. Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes. J Virol 2006; 80: 5292-5300.
12. Waarts BL, Bittman R, Wilschut J. Sphingolipid and cholesterol dependence of alphavirus membrane fusion. Lack of correlation with lipid raft formation in target liposomes. J Biol Chem 2002; 277: 38141-38147.
13. Takeda M, Leser GP, Russell CJ, Lamb RA. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A 2003; 100: 14610-14617.
14. Sattentau Q. Avoiding the void: Cell-to-cell spread of human viruses. Nat Rev Microbiol 2008; 6: 815-826.
15. Rudnicka D, Feldmann J, Porrot F, et al. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol 2009; 83: 6234-6246.
16. Jolly C, Sattentau QJ. Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J Virol 2005; 79: 12088-12094.
17. Leser GP, Lamb RA. Influenza virus assembly and budding in raft-derived microdomains: A quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology 2005; 342: 215-227.
18. Chen BJ, Takeda M, Lamb RA. Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol 2005; 79: 13673-13684.
19. Schmitt AP, Lamb RA. Escaping from the cell: Assembly and budding of negative-strand RNA viruses. Curr Top Microbiol Immunol 2004; 283: 145-196.
20. Ilnytska O, Santiana M, Hsu NY, et al. Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 2013; 14: 281-293.
21. Fine-Coulson K, Reaves BJ, Karls RK, Quinn FD. The role of lipid raft aggregation in the infection of type II pneumocytes by Mycobacterium tuberculosis. PLoS One 2012; 7: E45028.
22. Rodriguez NE, Gaur Dixit U, Allen LA, Wilson ME. Stage-specific pathways of Leishmania infantum chagasi entry and phagosome maturation in macrophages. PLoS One 2011; 6: E19000.
23. Meckes DG Jr, Menaker NF, Raab-Traub N. Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation. J Virol 2013; 87: 1301-1311.
24. Mannova P, Fang R, Wang H, et al. Modification of host lipid raft proteome upon hepatitis C virus replication. Mol Cell Proteomics 2006; 5: 2319-2325.
25. Cui HL, Grant A, Mukhamedova N, et al. HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux. J Lipid Res 2012; 53: 696-708.
26. van 't Wout AB, Swain JV, Schindler M, et al. Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virol 2005; 79: 10053-10058.
27. Mujawar Z, Rose H, Morrow MP, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol 2006; 4: E365.
28. Ghosh J, Das S, Guha R, et al. Hyperlipidemia offers protection against Leishmania donovani infection: Role of membrane cholesterol. J Lipid Res 2012; 53: 2560-2572.
29. Rub A, Dey R, Jadhav M, et al. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol 2009; 10: 273-280.
30. Rabhi I, Rabhi S, Ben-Othman R, et al. Transcriptomic signature of Leishmania infected mice macrophages: A metabolic point of view. PLoS Negl Trop Dis 2012; 6: E1763.
31. Kumar S, Naqvi RA, Khanna N, Rao DN. Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy. Mol Immunol 2011; 48: 1178-1190.
32. Coppens I, Joiner KA. Host but not parasite cholesterol controls toxoplasma cell entry by modulating organelle discharge. Mol Biol Cell 2003; 14: 3804-3820.
33. Coppens I. Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat Rev Microbiol 2013; 11: 823-835.
34. Ehrenman K, Sehgal A, Lige B, et al. Novel roles for ATP-binding cassette G transporters in lipid redistribution in toxoplasma. Mol Microbiol 2010; 76: 1232-1249.
35. Lige B, Sampels V, Coppens I. Characterization of a second sterol-esterifying enzyme in toxoplasma highlights the importance of cholesterol storage pathways for the parasite. Mol Microbiol 2013; 87: 951-967.
36. Labaied M, Jayabalasingham B, Bano N, et al. Plasmodium salvages cholesterol internalized by LDL and synthesized de novo in the liver. Cell Microbiol 2011; 13: 569-586.
37. Yam XY, Birago C, Fratini F, et al. Proteomic analysis of detergent-resistant membrane microdomains in trophozoite blood stage of the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics 2013; 12: 3948-3961.
38. Wunder C, Churin Y, Winau F, et al. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 2006; 12: 1030-1038.
39. Casabon I, Zhu SH, Otani H, et al. Regulation of the KstR2 regulon of Mycobacterium tuberculosis by a cholesterol catabolite. Mol Microbiol 2013; 89: 1201-1212.
40. Mittal K, Welter BH, Temesvari LA. Entamoeba histolytica: Lipid rafts are involved in adhesion of trophozoites to host extracellular matrix components. Exp Parasitol 2008; 120: 127-134.
41. Koushik AB, Powell RR, Temesvari LA. Localization of phosphatidylinositol 4,5-bisphosphate to lipid rafts and uroids in the human protozoan parasite entamoeba histolytica. Infect Immun 2013; 81: 2145-2155.
42. Ye J. Hepatitis C virus: A new class of virus associated with particles derived from very low-density lipoproteins. Arterioscler Thromb Vasc Biol 2012; 32: 1099-1103.
43. Schaefer EA, Chung RT. HCV and host lipids: An intimate connection. Semin Liver Dis 2013; 33: 358-368.
44. Syed GH, Tang H, Khan M, et al. Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. J Virol 2014; 88: 2519-2529.
45. Periard D, Telenti A, Sudre P, et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 1999; 100: 700-705.
46. Rose H, Low H, Dewar E, et al. The effect of HIV infection on atherosclerosis and lipoprotein metabolism: A one year prospective study. Atherosclerosis 2013; 229: 206-211.
47. Rose H, Woolley I, Hoy J, et al. HIV infection and high-density lipoprotein: The effect of the disease vs the effect of treatment. Metabolism 2006; 55: 90-95.
48. Asztalos BF, Mujawar Z, Morrow MP, et al. Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis 2010; 202: 614-623.
49. Cui HL, Ditiatkovski M, Kesani R, et al. HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis. FASEB J 2014; 28: 2828-2839.
50. Aqil M, Naqvi AR, Mallik S, et al. The HIV Nef protein modulates cellular and exosomal miRNA profiles in human monocytic cells. J Extracell Vesicles 2014; 3: 23129-23140.
51. Ramcharran D, Wahed AS, Conjeevaram HS, et al. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naive chronic hepatitis C type 1-infected cohort. J Viral Hepat 2011; 18: E144-e152.
52. Visser BJ, Wieten RW, Nagel IM, Grobusch MP. Serum lipids and lipoproteins in malaria-a systematic review and meta-analysis. Malar J 2013; 12: 442.
53. Ghosh J, Bose M, Roy S, Bhattacharyya SN. Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe 2013; 13: 277-288.
54. Wang D, Xia M, Yan X, et al. Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circ Res 2012; 111: 967-981.
55. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19: 576-585.
56. Sayin Sama I, Wahlström A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabol 2013; 17: 225-235.
57. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241241.
58. Bailey CC, Huang IC, Kam C, Farzan M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog 2012; 8: E1002909.
59. Brass AL, Huang IC, Benita Y, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009; 139: 1243-1254.
60. Lu J, Pan Q, Rong L, et al. The IFITM proteins inhibit HIV-1 infection. J Virol 2011; 85: 2126-2137.
61. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 2013; 13: 452-464.
62. Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature 2005; 438: 612-621.
63. Liu SY, Aliyari R, Chikere K, et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 2013; 38: 92-105.
64. Morrow MP, Grant A, Mujawar Z, et al. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol Pharmacol 2010; 78: 215-225.
65. Hanley TM, Viglianti GA. Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms. J Virol 2011; 85: 10834-10850.
66. Bocchetta S, Maillard P, Yamamoto M, et al. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis c virus infection. PLoS One 2014; 9: E92140.